Middletown, CT, United States of America

Hatice Belgin Gulgeze


Average Co-Inventor Count = 7.7

ph-index = 4

Forward Citations = 63(Granted Patents)


Location History:

  • New Haven, CT (US) (2002)
  • Izmir, TR (2005)
  • Middletown, CT (US) (2003 - 2006)

Company Filing History:


Years Active: 2002-2006

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Hatice Belgin Gulgeze: Innovator in HIV Research

Introduction

Hatice Belgin Gulgeze is a prominent inventor based in Middletown, CT (US). She has made significant contributions to the field of HIV research, holding a total of 6 patents. Her work focuses on developing compounds that can effectively inhibit HIV integrase, a crucial enzyme in the HIV replication process.

Latest Patents

Gulgeze's latest patents include innovative compounds that are useful for treating HIV. One of her notable inventions involves HIV integrase inhibitors, which are disclosed having a general formula where R, R, and B are defined in the specification. Additionally, she has developed acyl sulfonamides as inhibitors of HIV integrase, which are designed to treat AIDS or ARC by administering these specific compounds.

Career Highlights

Gulgeze is currently associated with Bristol-Myers Squibb Company, where she continues her research and development efforts. Her work has been instrumental in advancing therapeutic options for individuals affected by HIV.

Collaborations

Some of her notable coworkers include Kuo-Long Yu and Rita Civiello, who have collaborated with her on various projects related to HIV research.

Conclusion

Hatice Belgin Gulgeze's contributions to HIV research through her patents and collaborations highlight her commitment to improving treatment options for this global health issue. Her innovative work continues to pave the way for advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…